Literature DB >> 16385830

[Insulin allergy: background, diagnosis and treatment].

J Wonders1, E M W Eekhoff, R Heine, D P Bruynzeel, T Rustemeyer.   

Abstract

An allergic reaction develops in 2.4% of patients that use insulin. This ranges in severity from erythema and pruritus to life-threatening anaphylaxis. llergic reactions to insulin usually occur within a few hours after an injection and are usually due to a local or systemic type I IgE-mediated hypersensitivity reaction. Despite considerable research into the immunogenicity of insulin, this has not yet been clarified completely and allergic reactions to insulin still occur. A systematic diagnostic approach is essential for an adequate treatment plan. A blood test for anti-insulin antibodies and intradermal skin tests are of great importance. There are many options available for the treatment of insulin allergy and each patient must therefore be evaluated individually.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385830

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  4 in total

Review 1.  Diabetes mellitus and the skin.

Authors:  E Makrantonaki; D Jiang; A M Hossini; G Nikolakis; M Wlaschek; K Scharffetter-Kochanek; C C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report.

Authors:  Jennifer Badik; Jimmy Chen; Kira Letvak; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

Review 3.  Insulin as an autoantigen in NOD/human diabetes.

Authors:  Li Zhang; Maki Nakayama; George S Eisenbarth
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

4.  Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report.

Authors:  Benjamin J Wheeler; Barry J Taylor
Journal:  J Med Case Rep       Date:  2012-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.